The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.
Yes just superb - an aim share where you can sleep well the night before results
Another winning year but so much more - no equity funding for expansion plans next year, moving to medical devices entity , all sorts of initiatives - these results are stuffed full of optimism. What a company - great directors leading a highly motivated and engaged work force
The problem is we are powerless to change anything. If you hold shares in a nominee account then; as I found out recently, you cannot use your shares to call for an EGM. Write to your MP - as totally wrong
I do think however that for the first time in many years the company has a number of initiatives that may finally deliver shareholder/company returns
I may be wrong of course but this company has spent several years establishing a strong foundation after a period of turmoil. That foundation appears rock solid with distribution agreements in place, regulatory approvals just around the corner and demonstrated demand for its products. Honest, entrepreneurial management with a strong team under them and new manufacturing capability to come in the years ahead - it has been a lot of fun (for a change with aim companies) to be part of the project
Going to be a powerhouse in my view
Yes, shocking news
I am surprised they were able to raise this money so quickly - at least that should mean we fall no further then 5p this am - a third of what I bought for a few months ago - no choice but to hang on